Essentra’s Growth Potential and Recovery Amidst Market Challenges: A Buy Recommendation

Jefferies analyst Andrew Douglas maintained a Buy rating on Essentra today and set a price target of p170.00.

Andrew Douglas has given his Buy rating due to a combination of factors that highlight Essentra’s potential for recovery and growth. Despite facing challenges in mixed end markets, Essentra has demonstrated robust sales growth in its 3Q25 update, with constant-FX growth exceeding expectations. The company’s pricing strategies, particularly in the Americas, and effective cost management have contributed positively, alongside maintaining a cash conversion rate above 100%.
While there are concerns about the negative mix impact from higher growth in lower-margin areas like Turkey, which may affect margins and lead to downgrades in EBITA and PBT/EPS forecasts, the overall recovery potential remains strong. Essentra’s opportunities in volume and margin recovery, pricing, and potential mergers and acquisitions present a compelling case for future performance. A more favorable macroeconomic environment could further enhance the stock’s appeal, reinforcing the Buy rating despite short-term pressures.